Joseph Senesac, MBA

Joseph has 30 years of industrial experience in cell and gene therapy including 14 years in cell therapy at Bellicum Pharmaceuticals and 13 years in cell and gene therapy at Introgen Therapeutics. His expertise resides in process and analytical development and GMP manufacturing of viral vectors and gene-modified cell therapy products. He has extensive experience in building CMC strategies and mastered execution of these plans. He successfully reported CMC and GMP plans to regulatory agencies such as FDA, clinching multiple IND along the way across multiple types of cell therapies. To complement his CMC background, Joseph obtained the RAC certification for the United States and Europe from the Regulatory Affairs Professional Society. He also led successfully a Module 3 for the first gene therapy BLA filed for a novel gene therapy biotech in the US.

Besides his passion to build novel technologies in cell and gene therapy, Joseph works on old Alfa Romeos and has a 1968 Alfa GTA 1300 and a 1958 Alfa 750 Giulietta Spider Veloce. He won best in class in the US national Alfa Romeo Owners Club concours d’elegance with vintage Alfas multiple times. He is married with two daughters.

He holds a BA in Chemistry and Economics from Knox College, a BS from the University of Houston in Biology, and an MBA from the University of Colorado, Colorado Springs.